Avenue Therapeutics, Inc.
ATXI- Exchange
- OTC
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001644963
No open-market purchases or sales by Avenue Therapeutics, Inc. insiders were filed in the last 90 days; no institution reported holding it in 13F filings for Q2 2026; no superinvestor holds it.
Q3 2021 vs. Q2 2021
How the institutions holding Avenue Therapeutics, Inc. changed between Q2 2021 and Q3 2021.
All holders in Q3 2021All holders in Q2 2021
| Measure | Q2 2021 | Q3 2021 | Change |
|---|---|---|---|
| Holders | 29 | 21 | −8 |
| Shares | 1.15M | 1.09M | −60.7K (−5.3%) |
| Value | $2.88M | $1.62M | −$1.26M (−43.7%) |
New holders (3)
Institutions that held Avenue Therapeutics, Inc. at the end of Q3 2021 but not at the end of Q2 2021.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Citadel Advisors LLC | 27,555 | $41.0K | 0.00% |
| Kestra Advisory Services, LLC | 22,500 | $34.0K | 0.00% |
| Capital Analysts, LLC | 601 | $1.00K | 0.00% |
Sold out (11)
Institutions that held Avenue Therapeutics, Inc. at the end of Q2 2021 and filed for Q3 2021 without it.
| Institution | Shares, Q2 2021 | Value, Q2 2021 |
|---|---|---|
| Advisory Services Network, LLC | 35,121 | $88.0K |
| Ergoteles LLC | 30,400 | $76.0K |
| Virtu Financial LLC | 26,373 | $66.0K |
| Goldman Sachs Group Inc | 23,224 | $58.0K |
| Occudo Quantitative Strategies LP | 14,398 | $36.0K |
| Jane Street Group, LLC | 13,359 | $34.0K |
| XTX Topco Ltd | 10,864 | $27.0K |
| Parametric Portfolio Associates LLC | 10,554 | $26.0K |
| JPMorgan Chase & Co | 665 | $2.00K |
| The PNC Financial Services Group, Inc. | 198 | $0 |
| New York State Common Retirement Fund | 60 | $0 |